News
Zev A. Wainberg, MD, discussed the significance of the immune response signals in a phase 1 trial of an amphiphile vaccine for pancreatic cancer.
Eredivisie history was written in Velsen-Zuid when PEC Zwolle midfielder Jadiel Pereira da Gama made his debut and thus ...
An 'off-the-shelf' vaccine may help prevent or delay cancer recurrence in people with hard-to-treat colorectal or pancreatic ...
5h
TipRanks on MSNPfizer’s Latest Clinical Trial: A New Hope for KRAS-Mutated Tumors
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Study Overview: Pfizer Inc. is conducting a Phase 1 open-label study ...
6h
TipRanks on MSNAstraZeneca’s Selumetinib Study Update: Potential Game-Changer for KRAS-Positive NSCLC
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The FDA’s announcement of Papzimeos’ approval contained an unusual quote from newly reinstated CBER director Vinay Prasad. Elsewhere, Eli Lilly and Superluminal Medicines struck a deal.
New clinical data reveals promising efficacy of VS-7375, a KRAS G12D inhibitor, in advanced lung cancer, highlighting its ...
AbbVie unveiled a $195 million investment to expand active pharmaceutical ingredient manufacturing in the U.S. Bloomberg reported that BlinkRx, a company that has Donald Trump Jr. on its board, just ...
In dementia, problematic proteins build up in brain cells, making it harder for the cells to work effectively. Researchers ...
Berlin: Bayer and Kumquat Biosciences Inc., a clinical-stage biotech company, have announced that they have entered into an ...
Dementia-like protein clumps found in pancreatic precancer mouse cells point to autophagy defects, offering cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results